Avacincaptad pegol Uses, Dosage, Side Effects and more
Avacincaptad pegol is under investigation in clinical trial NCT03362190 (ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)).
| Trade Name | Avacincaptad pegol |
| Generic | Avacincaptad pegol |
| Avacincaptad pegol Other Names | Avacincaptad pegol |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
